fbpx
Sign up now!
Don't show this again
Download the report!Continue to Site >
or wait 7 secs

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Pig Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
PORK POULTRY
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis

.

ASF protein discovery offers vaccine development potential

Scientists have identified specific proteins in the African swine fever virus (ASF) that could pave the way for development of a vaccine against the deadly disease.

Researchers at the Pirbright Institute in the UK screened proteins in the virus to pinpoint the ones that are most likely to trigger an immune response in pigs.

By utilizing those proteins, they hope they will eventually be able to protect herds against the disease, which has led to the culling of millions of pigs worldwide.

In a study published in Frontiers in Immunology, scientists looked for virus proteins that activated an immune response in pigs that had been previously infected with a weakened form of ASF.

Those 18 proteins were then transferred into viral vectors — viruses which deliver the ASF proteins to pig cells but are not harmful to the animals.

Dr. Chris Netherton, head of Pirbright’s ASF vaccination group, said the virus has more than 150 proteins, and understanding which of those triggers an immune response is vital to developing this type of vaccine.

“Now we have identified proteins that activate pig immune cells, we can work on optimizing the vaccine components to ensure pigs are protected against virulent ASF strains,” he said.

ASF infects all pigs and wild boar and can cause fever, loss of appetite, vomiting and bloody diarrhea. The disease is often deadly, with some strains approaching case fatality rates of 100%.

ASF has already resulted in the culling of over 1.1m pigs in China and nearly 2.5m pigs in Vietnam alone.

Culling, quarantine and strict biosecurity measures are currently the only defenses farmers can use to prevent ASF from spreading, making the development of a safe and effective vaccine critical.

While there are various types of ASF vaccine in development, progress is slow because relatively little is known about the virus and how the immune system responds to it, a Pirbright spokesman said.

Vaccines made with inactivated viruses have not offered protection to domestic pigs, and although live attenuated vaccines — which contain weakened versions of a live virus — show promise for protection, more testing is needed to ensure their safety.

Pirbright researchers therefore hope these vector vaccines will provide an alternative, which could help to control the spread of the disease, the spokesman added.

Read more




Posted on October 29, 2019

tags: ,
RELATED NEWS



You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.